CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 17 enrolled
Drug / intervention
Water +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01128829
NCT01128829N/ACompleted
CompareCT.gov

Regulation of Incretin Release by Non-nutritive Sweeteners in Humans

Washington University School of Medicine·interventional·Posted May 24, 2010·Updated Dec 22, 2014

In Brief

A clinical study evaluating Water and Sucralose for Obesity. Completed, enrolled 17 participants across 1 site.

Detailed Summary

Several sugar-replacement sweeteners are currently on the market, including saccharine (ex. Sweet'N Low), aspartame (ex. Equal), and sucralose (ex. Splenda). The purpose of this study is to examine wether non caloric sweeteners affects how well the body works to control blood sugar. The study includes detailed blood sugar testing after drinking liquids that may contain sucralose. The investigators hypothesize that drinking liquids with sucralose will effect the amounts of specific appetite-affecting substances naturally produced by the body.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 24, 2010
Enrollment StartMay 1, 2010
Primary CompletionFeb 1, 2012
Study CompletionOct 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 16.1 years ago

Interventions

Waterother

60 ml of water were drank 10 min before doing a OGTT

Sucraloseother

60 ml of 2 millimolar sucralose were drank 10 min before doing a OGTT